Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas

Abroad (travel likely)RecruitingPHASE2

Conditions

Digestive System Neuroendocrine Neoplasm · Lung Neuroendocrine Neoplasm · Malignant Solid Neoplasm · Pancreatic Neuroendocrine Neoplasm

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Roswell Park Cancer Institute, Buffalo, New York, United States
Contact: Study coordinator (Jasmeet Kaur, MD) · Jasmeet.Kaur@RoswellPark.org · 716-845-1300
Contact: Principal Investigator (Jasmeet Kaur)

Study leads

Jasmeet Kaur, MD
Principal Investigator
Roswell Park Cancer Institute

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

Neuroendocrine Neoplasm · Neuroendocrine Neoplasm of Gastrointestinal Tract · Neuroendocrine Neoplasm of Lung

Abroad (travel likely)Recruiting

Mexico City, Mexico · Mexico City, Mexico

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Metastatic Malignant Solid Neoplasm · Metastatic Melanoma · Pathologic Stage IIIC Cutaneous Melanoma AJCC v8

Abroad (travel likely)RecruitingPHASE1

Duarte, United States · Los Angeles, United States

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Advanced Biliary Tract Carcinoma · Advanced Head and Neck Squamous Cell Carcinoma · Advanced Hepatocellular Carcinoma

Abroad (travel likely)RecruitingPHASE4

Portland, United States